Medvi vs EnhanceMD: Coaching-Heavy GLP-1 Care vs Flat-Rate Lab Monitoring in 2026

Short Answer: Medvi for Coaching, EnhanceMD for Predictable Lab-Monitored Pricing

Choose Medvi if you want a more guided GLP-1 program: video consultations, regular provider check-ins, nutrition guidance, meal planning, dose optimization, side-effect support, coaching, free shipping, and a brand Wegovy route. The local PeptidePub review rates Medvi 4.1 out of 5 and lists GLP-1 injections from $179/month, GLP-1 tablets from $249/month, and a brand Wegovy pill or injection route at a $99 membership plus medication cost.

Choose EnhanceMD if your top priority is predictable compounded GLP-1 pricing with lab monitoring. PeptidePub rates EnhanceMD 4.3 out of 5 and lists GLP-1 Core semaglutide at $49 first month, then $212/month; GLP-1 Advanced tirzepatide at $99 first month, then $280/month; and GLP-1 Elite semaglutide plus tirzepatide at $189 first month, then $322/month. Labs are included every 6 months.

The clean buyer answer: Medvi is stronger for first-time GLP-1 users who want human support. EnhanceMD is stronger for self-directed buyers who want flat-rate pricing, no dose-escalation fees, and metabolic labs.

Both reviews discuss compounded GLP-1 access. Compounded products are not FDA-approved finished drugs, and they are not generic Ozempic, Wegovy, Mounjaro, or Zepbound.

Comparison Snapshot

Pricing: Medvi lists injections from $179/month and tablets from $249/month in the local review. If $179/month holds all year, that is $2,148/year. Tablets at $249/month equal $2,988/year. The Wegovy route is $99/month membership plus medication cost, so membership alone is $1,188/year before the drug.

EnhanceMD is clearer in the local review. Semaglutide is $49 first month plus 11 months at $212, or $2,381 in year one. Tirzepatide is $99 first month plus 11 months at $280, or $3,179 in year one. The Elite semaglutide plus tirzepatide combo is $189 first month, then $322/month.

Format: Medvi lists weekly injections and daily dissolvable tablets. EnhanceMD is injections only, with no oral, lozenge, or drop format in the local review.

Support: Medvi emphasizes video consultation, provider check-ins, nutritional guidance, meal planning, dose optimization, side-effect management, and health coaching. EnhanceMD includes licensed-provider consultation, ongoing provider support, dose adjustments as needed, and metabolic lab testing every 6 months, but no dedicated structured coaching program in the local review.

Best fit: Medvi if you want support around the medication. EnhanceMD if you want predictable all-dose pricing, lab monitoring, and fewer pricing surprises.

Price and Year-One Math

Medvi may look cheaper if the $179/month injection price is truly recurring. At that rate, injections cost $2,148/year. But the pricing needs a checkout check. A Dosemate result accessed 2026-07-08 says Medvi compounded GLP-1 injections are $179 first month and $299/month for refills. If that applies, year one is $3,468. The Medvi official GLP-1 result showed GLP-1 injections, GLP-1 tablets, and the $99 membership plus medication cost Wegovy route, but dynamic placeholders appeared for semaglutide injection and tablet prices.

EnhanceMD's advantage is pricing clarity. PeptidePub lists semaglutide at $49 first month, then $212/month, or $2,381 in year one. Tirzepatide is $99 first month, then $280/month, or $3,179 in year one. Microdosing tirzepatide is $169/month. NAD+ injections are $169/month.

External EnhanceMD pricing also shows how commitment length changes the bill. Core semaglutide can be $212/month on 12 months, $224/month on 6 months, $237/month on 3 months, or $249/month month-to-month. Advanced tirzepatide can be $280/month on 12 months, $296/month on 6 months, $313/month on 3 months, or $329/month month-to-month. Elite can be $322/month on 12 months, $341/month on 6 months, $360/month on 3 months, or $379/month month-to-month.

Bottom line on price: verify Medvi refill pricing before paying. Use /go/enhancedmd, /go/enhancedmd-semaglutide, or /go/enhancedmd-tirzepatide when predictable pricing matters most.

Clinical Oversight, Labs, and Evidence Context

Medvi's oversight pitch is higher-touch. The local review lists an initial video consultation with a licensed provider, regular provider check-ins, proactive dose management, nutritional guidance, meal planning support, side-effect management, health coaching access, and free medication delivery. That makes Medvi the more natural fit for a first-time GLP-1 buyer who wants conversation, accountability, and lifestyle help.

EnhanceMD's oversight pitch is more data-driven. The local review lists a licensed-provider consultation, ongoing provider support, dose adjustments as needed, and metabolic lab testing every 6 months. Labs can help follow metabolic health beyond scale weight, but they do not guarantee better outcomes for every patient.

Both provider reviews discuss compounded semaglutide and tirzepatide. For molecule background, see /peptides/semaglutide and /peptides/tirzepatide.

The evidence context is strong for the active ingredients, but it should be framed correctly. In STEP 1, semaglutide 2.4 mg produced mean body-weight change of -14.9% at week 68 versus -2.4% with placebo. In SURMOUNT-1, tirzepatide groups showed average weight reductions of 16.0%, 21.4%, and 22.5% at 72 weeks for 5 mg, 10 mg, and 15 mg groups, compared with 2.4% placebo in Lilly's summary.

Those numbers are active-ingredient and brand-drug evidence context. They do not prove that compounded versions have identical trial evidence, FDA approval, manufacturing controls, or outcomes.

Safety, Compounding, and Buyer Verification

Do not treat either provider as a shortcut around medical screening. Also do not treat compounded semaglutide or tirzepatide as generic Ozempic, Wegovy, Mounjaro, or Zepbound. For the broader regulatory comparison, use /blog/compounded-vs-brand-glp1.

FDA's 2026-04-01 GLP-1 compounding clarification says compounded drugs must meet section 503A or 503B conditions to qualify for exemptions. Under 503A, compounded drugs are made for an individual patient after receipt of a valid prescription. FDA also says compounders cannot regularly or in inordinate amounts compound products that are essentially copies of commercially available drugs.

For 503B outsourcing facilities, FDA says bulk drug substances are restricted unless the substance appears on the 503B bulks list or the drug is on FDA's shortage list at the time of compounding, distribution, and dispensing. FDA says semaglutide and tirzepatide do not currently appear on the 503B bulks list or FDA drug shortage list in that clarification.

FDA also says compounded drugs are not FDA-approved finished drugs and are not reviewed by FDA for safety, effectiveness, and quality before marketing.

Before paying either provider, verify the exact medication, compounded versus brand status, pharmacy name, prescriber credentials, state eligibility, recurring price, refill price, dose escalation fees, lab timing, shipping, supplies, refund if not prescribed, cancellation terms, and side-effect support.

Who Should Choose Medvi

Choose Medvi if support matters more than the absolute lowest medication-only price. It is the better fit for buyers who want video consults, provider check-ins, nutrition help, meal planning, coaching, dose optimization, and side-effect management. That is especially useful if you are new to GLP-1 treatment and want more than a prescription-by-mail experience.

Medvi is also the better fit if you want a brand Wegovy path. The local review lists brand Wegovy pill or injection access at $99 membership plus medication cost. EnhanceMD's local review does not list a brand-name Ozempic or Wegovy pathway.

The tradeoff is pricing clarity. Medvi's local review lists injections from $179/month and tablets from $249/month, but external pricing signals suggest $179 first month and $299/month refills may apply. Before using /go/medvi, confirm whether $179 is first month only, a starting price, or the recurring price.

Who Should Choose EnhanceMD

Choose EnhanceMD if predictable pricing and labs matter most. It is stronger for buyers who want $49 first-month semaglutide, $99 first-month tirzepatide, no dose-escalation fees, all-dose flat pricing, and metabolic lab testing every 6 months.

EnhanceMD is less ideal if you want video consultations, dedicated coaching, meal planning, daily tablet formats, lozenges, drops, or a brand Wegovy path. It is compounded only and injections only in the local review, and it is a smaller platform than some competitors.

FAQ

Is Medvi cheaper than EnhanceMD? Maybe, but only if Medvi's $179/month injection price applies all year. That would be $2,148/year. External pricing signals say $179 first month and $299/month refills may apply, which would be $3,468/year. EnhanceMD semaglutide is $49 first month, then $212/month, or $2,381 in year one.

Does EnhanceMD include labs? Yes. The local review says metabolic lab testing is included every 6 months. Medvi's local review emphasizes video consults, provider check-ins, nutrition guidance, meal planning, coaching, dose optimization, and side-effect support, not scheduled labs.

Which has better support? Medvi is the more support-forward option. It lists video consultations, regular provider check-ins, nutrition guidance, meal planning, coaching, dose optimization, and side-effect management. EnhanceMD has provider support and lab monitoring, but no dedicated structured coaching program in the local review.

Which has more predictable GLP-1 pricing? EnhanceMD. The local review lists flat-rate pricing with no dose-escalation fees. Medvi buyers should verify recurring refill pricing and whether the listed starting price changes after month one.

Are Medvi and EnhanceMD selling FDA-approved generics? No. The reviews discuss compounded semaglutide and tirzepatide access, and Medvi also lists a brand Wegovy path. Compounded products are not FDA-approved finished drugs or FDA-approved generics.

Bottom Line

Medvi wins for buyers who want a more supported GLP-1 program. Use /go/medvi if video consults, provider check-ins, nutrition guidance, meal planning, coaching, dose optimization, side-effect help, free medication delivery, and a Wegovy brand pathway are worth possible pricing ambiguity.

EnhanceMD wins for buyers who want predictable compounded pricing. Use /go/enhancedmd if you want flat-rate pricing, first-month affordability, no dose escalation fees, and labs every 6 months. Use /go/enhancedmd-semaglutide for semaglutide intent and /go/enhancedmd-tirzepatide for tirzepatide intent.

The practical decision is not which brand sounds better. It is which tradeoff you prefer. Medvi gives more human support around the program. EnhanceMD gives clearer price math and scheduled lab monitoring.

Before checkout, verify pricing, product identity, pharmacy, refill terms, cancellation terms, state eligibility, and medical fit. That verification matters more than any headline monthly price.